HC Wainwright & Co. Reiterates Buy on ImmunoPrecise Antibodies, Maintains $9 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterated a Buy rating on ImmunoPrecise Antibodies (NASDAQ:IPA) with a maintained price target of $9.

March 15, 2024 | 1:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ImmunoPrecise Antibodies maintains a Buy rating and a $9 price target from HC Wainwright & Co.
The reiteration of a Buy rating and maintenance of a $9 price target by a reputable analyst firm like HC Wainwright & Co. typically signals a positive outlook on the stock, suggesting potential upside. This can influence investor sentiment positively in the short term, likely leading to an increase in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100